Four-Headquarters Structure for Company-Wide Technology Functions
First written in FY2017. 2 of 5 entries say "Reframed", first in FY2019. Latest entry: FY2021.
Nitto Denko moved to the "Worse" side of this theme in 2021, 2 years before the typical company in this theme (2023).
The whole theme swung hardest in 2026: 2 of 8 companies on the "Worse" side.
4 other companies' latest entry also says "Reframed".
- FY2021ReframedAnnual report
「The company-wide technology organization consists of 4 departments—the R&D Division, New Business Division, Nucleic Acid Drug Development Division and New Mobility Business Development Department—which work closely with the Technology Intellectual Property Strategy Division to develop future businesses and the technologies that support them.」
The technology organization was reorganized from the previous structure centered on 3 divisions into a 4-department structure, including the newly established New Mobility Business Development Department, working in coordination with the Technology Intellectual Property Strategy Division. - FY2020AdvancedAnnual report
「The company-wide technology organization is centered on the R&D, New Business and Nucleic Acid Drug Development divisions, which work closely with the Intellectual Property Division and Process Technology Division to develop future businesses and the technologies that support them. It has also established an Innovation Marketing Center within the organization to pursue market-oriented initiatives from an early stage.」
The company established an Innovation Marketing Center within the technology organization centered on 3 divisions, creating a structure that considers market needs from an early stage. - FY2019ReframedAnnual report
「The company-wide technology organization is centered on 3 divisions: the R&D Division, comprising the Core Technology Research Center and Sustainable Technology Research Center; the New Business Division, comprising the Information Interface Technology Center and Space Innovation Technology Center; and the Nucleic Acid Drug Development Division. These divisions work closely with the Intellectual Property Division and Process Technology Division to develop future businesses and the technologies that support them.」
The organization was reorganized from the previous 4-division structure into one centered on the R&D, New Business and Nucleic Acid Drug Development divisions, with the Intellectual Property and Process Technology divisions working closely with them. - FY2018RestatedAnnual report
「The company-wide technology organization consists of the R&D Division, comprising the Core Technology Research Center, Sustainable Technology Research Center and Life Science Research Center, and the New Business Division, comprising the Information Interface Technology Center and Space Innovation Technology Center, as its two core divisions. The Intellectual Property Division and Process Technology Division work closely with them to develop future businesses and the technologies that support them.」
The company reaffirms the 4-division structure in which the R&D and New Business divisions serve as the two core divisions, supported by close coordination with the Intellectual Property and Process Technology divisions. - FY2017First statedAnnual report
「From fiscal 2017, in addition to the existing R&D Division, the company established the New Business Division, Intellectual Property Division and Process Technology Division, creating a 4-division structure for the group-wide technology organization.」
The company reorganized its company-wide technology organization into 4 divisions by adding the New Business, Intellectual Property and Process Technology divisions to the R&D division.